Home › Multiple Myeloma › NCT04114084
Sleep Apnea in Patients With MGUS and MM
RecruitingObservational study
Who can join
Ages 18 to 99 · All sexes
Full eligibility criteria
Patients diagnosed with MGUS or MM who will be receiving a bone marrow biopsy as part of their standard of care are eligible to participate in this study
About the study
This study involves patients with plasma cell dyscrasia including monoclonal gammopathy of undetermined significance (MGUS) or multiple myeloma (MM), with and without sleep apnea, who are providing bone marrow specimens. Specimens will be obtained at the time that patients undergo a standard-of-care procedure in order to minimize discomfort and reduce any risk.
What is being tested
- Bone Marrow Aspirate and Biopsy (procedure)
Sponsor: Michael Tomasson · Participants: 200 · Started: May 23, 2019
Contact the study team
- Michael Tomasson, MD · Phone: 319-356-4200
Official record on ClinicalTrials.gov — NCT04114084
Locations in the U.S.
| Iowa | University of Iowa, Iowa City |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.